Trial Profile
Study of T900607-sodium in previously treated patients with ovarian cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2005
Price :
$35
*
At a glance
- Drugs T 900607 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.